Serum Immunoglobulin (G) as a Marker of Diabetic Nephropathy
Not Applicable
- Conditions
- Diabetic Nephropathies
- Interventions
- Diagnostic Test: serum immunoglobulin G level
- Registration Number
- NCT03212755
- Lead Sponsor
- Assiut University
- Brief Summary
Diabetes mellitus is a chronic disease that affects 366 million people worldwide ( 6.4 % of the adult population ) and is expected to rise to 522 million by 2030 . Diabetic nephropathy occurs in approximately one - third of all people with diabetes and is the leading cause of renal failure in developed and developing countries Diabetic nephropathy is a severe complication occurring in diabetic patients and it is associated with an increased risk of all- cause mortality , cardiovascular disease and progression to end stage renal disease , requiring costly renal replacement therapy in the form of dialysis or transplantation
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 75
Inclusion Criteria
- type 2 diabetic patients
Read More
Exclusion Criteria
- patients with diabetes type 1 ,
- pregnant and lactating females ,
- patients with any congenital disease , Infection , Smokers , alcoholics , and drug abusers .
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description group 1 serum immunoglobulin G level 25 diabetic patients without diabetic nephropathy group 2 serum immunoglobulin G level 25 type 2 diabetic patients with diabetic nephropathy group 3 serum immunoglobulin G level 25 healthy subjects
- Primary Outcome Measures
Name Time Method The number of patients with high level of immunoglobulin in serum 24 hours
- Secondary Outcome Measures
Name Time Method